Prescient Therapeutics (ASX:PTX) share price up 5% on Thursday

Prescient shares are enjoying an impressive run and are up 28% over the past 7 days of trading.

A group of science or medical professionals cheering good news in the lab.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

sdf

The Prescient Therapeutics Ltd (ASX: PTX) share price has gained a further 5% to trade at 23 cents on Thursday afternoon.

Prescient shares have been on the move over this past week and have climbed 28% into the green over this time.

What tailwinds are behind the Prescient share price lately?

The Prescient share price has been gaining steam since the company reported its FY21 earnings on 30 August.

In it, the company recognised an almost 6% downwards step in revenue to $66,285, whereas the loss after tax increased by 25% over the year.

The company also increased its net assets by $9.2 million to $20.4 million. The bolus of this increase was the issuance of share capital.

Investors are perhaps more concerned with the advancements of the company's "targeted therapies" PTX-100 and PTX-200.

Both therapies are compounds aimed at the treatment and prevention of cancer, by blocking the growth of tumours in the body.

Currently, PTX-100 has progressed through a Phase 1b trial over the year, "yielding encouraging results" according to the company.

The PTX-200 compound is also in a Phase 1b trial investigating its efficacy in patients with "relapsed and refractory acute myeloid leukaemia (AML)".

One clear takeout from the year was the development of Prescient's OmniCAR platform.

The OmniCAR segment is described as a "modular CAR platform created to overcome many of the well-documented limitations and challenges of the current CAR-T treatments, especially in the area of solid tumours".

For reference, CAR-T treatments are a new type of intervention that is used in immunotherapy and the treatment of cancer. The company made significant advancements in this segment over the course of FY21, according to the release.

There has been no other market-sensitive information released by the company over the past couple of days.

Therefore, it stands to reason that investors are buying Prescient shares on the back of this fundamental momentum.

Prescient share price snapshot

The Prescient share price has posted a 12-month gain of 221%. This has far outpaced the S&P/ASX 200 index (ASX: XJO), which has returned about 23% over the past year.

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors were nervous this Friday, ending the week on a sour note.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Share Gainers

Why EOS, Evolution Mining, Renascor, and Woodside shares are jumping today

These shares are ending the week on a high. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a volatile, but negative day for ASX investors this Thursday.

Read more »

Woman with an amazed expression has her hands and arms out with a laptop in front of her.
Share Gainers

Guess which ASX 200 stock turned $5,000 into $34,264 in just three years!

Investors have been piling into this ASX 200 stock for years, sending the share price soaring.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Share Gainers

Why Beach Energy, Meeka Metals, Monash IVF, and Qantas shares are racing higher today

These shares are having a better day than most on Thursday. But why?

Read more »

Rising gold share price represented by a green arrow on piles of gold block.
Share Gainers

2 ASX All Ords stocks that would already have more than doubled your money this year

These ASX All Ords stocks have gained 126% and 145% year to date. But how?

Read more »

Ten smiling business people wave to the camera after receiving some winning company news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was an historic day for the ASX, with the market setting a new record.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Fletcher Building, Johns Lyng, Pilbara Minerals, and Zip shares are charging higher

These shares are having a strong session on hump day. But why?

Read more »